← Full evidence page

For the cleanest result, disable browser headers and footers.

Dediabetes Evidence Brief

Sulfonylureas

Evidence related to Sulfonylureas.

Brief accessed
—

Full evidence pagehttps://www.dediabetes.com/evidence/sulfonylureas

Executive Summary

Sulfonylureas evidence appears to center on HbA1c.

Among 8 indexed studies and 3 interventions, the strongest signals are summarized from the available evidence. HbA1c appears to be one of the clearer current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Evidence Snapshot

Studies analyzed
8
Evidence relationships
27
Interventions
3
Outcomes
23
Strong evidence signals
1
Mixed evidence areas
1

Key Findings

  1. 01

    Across 4 studies, Glimepiride shows a consistent moderate positive signal for HbA1c.

  2. 02

    Across 2 studies, Gliclazide sustained release shows a moderate positive signal for Body weight.

  3. 03

    Across 2 studies, Gliclazide sustained release shows a moderate positive signal for HbA1c.

  4. 04

    Across 2 studies, Glimepiride shows a evidence signal for Body weight.

Question Highlights

What outcomes has Sulfonylureas been studied for?

HbA1c, Body weight, and Fasting Plasma Glucose (FPG) are among the most studied areas in relation to Sulfonylureas.

HbA1c, Body weight, and Hypoglycemic symptoms are among the best-supported options in the available evidence across 8 studies.

Read the full answer

Do Sulfonylureas lower HbA1c?

Sulfonylureas may lower HbA1c.

Strong evidence is based on 7 supporting studies.

Read the full answer

How does Sulfonylureas compare across studied outcomes?

HbA1c, Body weight, and Fasting Plasma Glucose (FPG) have available evidence for Sulfonylureas, but the comparison requires review of the underlying studies.

Evidence is available for both Body weight and Fasting Plasma Glucose (FPG); the underlying studies are needed for a direct comparison.

Read the full answer

Evidence Categories

The evidence is organized by how consistently it supports a conclusion and how much research is available.

Well-Supported Interventions

The strongest and most consistent evidence for improving this outcome.

Evidence is consistently positive across multiple studies.

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

HbA1c appears to have a consistent beneficial signal in the indexed evidence.

Leading examples

HbA1c

Evidence basis: 3 evidence pairs - 7 studies

Findings Requiring Careful Interpretation

Results that vary across studies or depend on population, study design, duration, or comparator.

Some evidence is positive, but results are not consistent across all studies.

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

HbA1c is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Leading examples

HbA1c · Body weight · Fasting Plasma Glucose (FPG)

Evidence basis: 9 evidence pairs - 7 studies

Emerging Areas of Research

Early positive signals that require additional high-quality research.

Early findings are encouraging, but stronger trials are needed.

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Body weight may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Leading examples

Body weight · HDL cholesterol · Hypoglycemic symptoms

Evidence basis: 5 evidence pairs - 5 studies

About this Evidence Brief

This brief summarizes research currently indexed by Dediabetes Evidence Intelligence. It is not a clinical guideline or personalized medical recommendation. Evidence classifications may change as additional studies are indexed.

Suggested citation

—